Capitol Hill Briefing - March 18th

Link to Paper

Can We Trust Our Medicines?

The authors of a new working paper will address the ongoing challenges of maintaining high quality standards for America’s drug supply. They will analyze how questionable standards of assessing bioequivalence has cast doubt on the efficacy of many medicines available in the U.S. marketplace, and how dangerous imports are even undermining our safety. They will expose these problems and explore possible solutions.

Wednesday, March 18th, 2015
9:00 - 10:00 A.M.
430 Dirksen Senate Office Building


Panelists
Roger Bate, PhD, American Enterprise Institute Scholar, will chair the panel, present the paper’s findings, and introduce the Safe Medicines Coalition.

Harry Lever, MD, Cardiologist, Cleveland Clinic, will discuss the ongoing problems with medicines he encounters in his medical practice.

Tod Cooperman, MD, Founder of Consumerlab.com, will share his experiences assessing drug quality and bioequivalence.

Preston Mason, PhD Cardiological Expert, Brigham and Women’s Hospital and Harvard Medical School, will discuss his scientific assessments of statin quality.

Dinesh Thakur, Whistleblower in Ranbaxy case and CEO of Medassure Corporation, will discuss how developments between the U.S. and India are affecting drug quality.

To RSVP or request more information, please contact info@safemedicinescoalition.org

© 2014 Safe Medicines Coalition Contact Us